Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award: Doctoral Foreign Study Award (DFSA)

Direct Payment

$105,000.00

Examining the role of toll-like receptor signalling in promoting DN2-like autoantibody-secreting cell development in Systemic Lupus Erythematosus

EF 2021-22

Résumé
SLE is a complex autoimmune disease that causes long-term distress, multi-organ damage, and occasional fatality in affected individuals. It also disproportionally affects women and individuals of African, Asian, or Hispanic descent. A complex network of disease factors is associated with SLE, ranging from genetic defects and hormonal dysregulation to environmental stimulations, medication and infection, which results in highly heterogeneous clinical manifestation and limited options for broadly effective therapeutic interventions. The cellular mechanisms driving the production of self-targeting antibody (autoantibodies), which induces recurrent inflammation in lupus, remain elusive and urge for extensive investigation. Studying how antibody secreting cells, which are the producers of autoantibodies, develop and differentiate under inflammatory environments are pertinent to understanding SLE disease progression. Here I propose to study the development and function of a lupus-associated B cell subset in mice with established autoantibody secreting potential, which are named DN2-like B cells. I hypothesize that the RNA sensor toll-like receptor-7 will be a main cellular driver for the activation and differentiation of DN2-like B cells into autoantibody secreting cells. I will establish and utilize a mouse model that allows the timely tracking of B cell kinetics to study the developmental trend and activation requirements of DN2-like B cells, to determine autoreactivity of DN2-like B cell-derived autoantibodies, and to define cellular precursors of DN2-like B cells. Utilizing a combination of clinically validated autoreactivity tests, advanced imaging and sequencing technologies, as well as fundamental immunology assays, this study will advance our current understanding of the fundamental biological circuitry behind inflammatory autoantibodies in lupus patients and point to potential future avenues for therapeutic development.
Programme
Doctoral Award: Doctoral Foreign Study Award (DFSA)
Bénéficiaire
Emplacement
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
457180
Name
Zhu Danni
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Examining the role of toll-like receptor signalling in promoting DN2-like autoantibody-secreting cell development in Systemic Lupus Erythematosus
Programtype2
Studentship Programs
Orgnameinp2
Direct Payment
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award: Doctoral Foreign Study Award (DFSA)
Keyworddelim
Adaptive Immunity; Autoantibodies; Autoimmune Disease; Autoreactive B Cells; B Cell Adoptive Transfer; Innate Immunity; Murine Models; Systemic Lupus Erythematosis; Tlr7; Toll-Like Receptors
Abstract
SLE is a complex autoimmune disease that causes long-term distress, multi-organ damage, and occasional fatality in affected individuals. It also disproportionally affects women and individuals of African, Asian, or Hispanic descent. A complex network of disease factors is associated with SLE, ranging from genetic defects and hormonal dysregulation to environmental stimulations, medication and infection, which results in highly heterogeneous clinical manifestation and limited options for broadly effective therapeutic interventions. The cellular mechanisms driving the production of self-targeting antibody (autoantibodies), which induces recurrent inflammation in lupus, remain elusive and urge for extensive investigation. Studying how antibody secreting cells, which are the producers of autoantibodies, develop and differentiate under inflammatory environments are pertinent to understanding SLE disease progression. Here I propose to study the development and function of a lupus-associated B cell subset in mice with established autoantibody secreting potential, which are named DN2-like B cells. I hypothesize that the RNA sensor toll-like receptor-7 will be a main cellular driver for the activation and differentiation of DN2-like B cells into autoantibody secreting cells. I will establish and utilize a mouse model that allows the timely tracking of B cell kinetics to study the developmental trend and activation requirements of DN2-like B cells, to determine autoreactivity of DN2-like B cell-derived autoantibodies, and to define cellular precursors of DN2-like B cells. Utilizing a combination of clinically validated autoreactivity tests, advanced imaging and sequencing technologies, as well as fundamental immunology assays, this study will advance our current understanding of the fundamental biological circuitry behind inflammatory autoantibodies in lupus patients and point to potential future avenues for therapeutic development.
Competitiondate
202110
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Zhu, Danni
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~